# PharmaCyte Biotech, Inc.: Form 8-K, filed Feb 15, 2012

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2012-02-15
- Accepted by EDGAR: Feb 15, 2012, 14:44 ET
- Period: 2012-02-09
- Accession: 0001262463-12-000033
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000126246312000033/nvlx_8kauditorchangenotifica.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000126246312000033/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000126246312000033/nvlx_8kauditorchangenotifica.htm

Filed Feb 15, 2012.
Source: SEC EDGAR, the filing index for accession 0001262463-12-000033. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
